Back to MORGAN STANLEY MORGAN STANLEY

PTGXPTGX
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PROTAGONIST THERAPEUTICS INC

MORGAN STANLEY holds 905,992 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $111.1M as of 2026-Q2. The position was decreased (-11.0% shares). PTGX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$111.1M

Current Shares

905,992

Total Value Change

+$99.1M

Total Shares Change

+560,699

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
905,992
-11.0%
$111.1M0.0%$122.58
0
2026-Q1
Increased
1M
+15.8%
$107.3M0.0%$91.30
35
2025-Q4
Increased
879,024
+14.4%
$76.8M0.0%$87.26
34
2025-Q3
Decreased
768,359
-11.6%
$51M0.0%$65.14
0
2025-Q2
Increased
868,963
+74.8%
$48M0.0%$55.69
44
2025-Q1
Decreased
497,105
-8.0%
$24M0.0%$48.88
0
2024-Q4
Decreased
540,315
-14.1%
$20.9M0.0%$38.51
0
2024-Q3
Increased
628,623
+82.0%
$28.3M0.0%$44.56
44
2024-Q2
New
345,293
-
$12M0.0%$34.65
39

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used